Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 4:34 PM
Ignite Modification Date:
2025-12-25 @ 2:25 PM
NCT ID:
NCT02502266
Recruitment Details:
Study opened on 05 Feb 2016. Phase 2 accrual completed on 16 Jun 2017 with 213 patients randomly assigned to 4 treatment arms. Enrollment to Arm IV (olaparib) was suspended after DMC review and 52 patients on Arm IV during phase 2 not included in phase 3 analysis. Phase 3 accrual started on 17 Dec 2018 with 349 patients including 4 Japanese patients enrolled to Phase 3 three arms by 02 Oct 2020. After that, 20 Japanese patients were enrolled but not included in the phase 3 analysis.
Study:
NCT02502266
Study Brief:
Results Section:
NCT02502266